These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22272627)

  • 21. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.
    Fan H; Zhang F; Hu J; Liu D; Zhao Z
    J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran.
    Ahmadi K; Soleimani A; Irani S; Kiani A; Ghanadi K; Noormohamadi Z; Sakinejad F
    J Gastrointest Cancer; 2018 Jun; 49(2):167-171. PubMed ID: 28220295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia.
    Pesmatzoglou M; Lourou M; Goulielmos GN; Stiakaki E
    Clin Dev Immunol; 2012; 2012():352059. PubMed ID: 23049596
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Majstorović D; Barišić A; Božović IB; Čače IB; Čače N; Štifanić M; Vraneković J
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methyltransferase haplotype is associated with Alzheimer's disease.
    Pezzi JC; Ens CM; Borba EM; Schumacher-Schuh AF; de Andrade FM; Chaves ML; Fiegenbaum M; Camozzato AL
    Neurosci Lett; 2014 Sep; 579():70-4. PubMed ID: 25038421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.
    de Bem CM; Pezzi JC; Borba EM; Chaves ML; de Andrade FM; Fiegenbaum M; Camozzato A
    Mol Biol Rep; 2016 Jul; 43(7):653-8. PubMed ID: 27188425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.
    Lambert JC; Mann DM; Harris JM; Chartier-Harlin MC; Cumming A; Coates J; Lemmon H; StClair D; Iwatsubo T; Lendon C
    J Med Genet; 2001 Jun; 38(6):353-5. PubMed ID: 11389157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.
    Araria-Goumidi L; Huguet JB; Lambert JC; Frigard B; Cottel D; Amouyel P; Chartier-Harlin MC
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1023-7. PubMed ID: 12111439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
    Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease.
    Li W; Yu Z; Hou D; Zhou L; Deng Y; Tian M; Feng X
    PLoS One; 2015; 10(4):e0125186. PubMed ID: 25902149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic factors associated with the predisposition to late onset Alzheimer's disease.
    Durmaz A; Kumral E; Durmaz B; Onay H; Aslan GI; Ozkinay F; Pehlivan S; Orman M; Cogulu O
    Gene; 2019 Jul; 707():212-215. PubMed ID: 31102717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia.
    Saradalekshmi KR; Neetha NV; Sathyan S; Nair IV; Nair CM; Banerjee M
    PLoS One; 2014; 9(5):e98182. PubMed ID: 24859147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer.
    Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J
    PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population.
    Zhao H; Du W; Gu D; Wang D; Xue F; Ge J; Sui T; Yang R
    Acta Haematol; 2009; 122(1):31-5. PubMed ID: 19696477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease.
    Arosio B; Bulbarelli A; Bastias Candia S; Lonati E; Mastronardi L; Romualdi P; Candeletti S; Gussago C; Galimberti D; Scarpini E; Dell'Osso B; Altamura C; MacCarrone M; Bergamaschini L; D'Addario C; Mari D
    Neurodegener Dis; 2012; 10(1-4):207-11. PubMed ID: 22261503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DNMT3B -579G>T Polymorphism Is Significantly Associated With the Risk of Gastric Cancer but not Lung Cancer in Chinese Population.
    Chen B; Wang J; Gu X; Zhang J; Zhang J; Feng X
    Technol Cancer Res Treat; 2017 Dec; 16(6):1259-1265. PubMed ID: 29332452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.
    Lao Y; Wu H; Zhao C; Wu Q; Qiao F; Fan H
    Biomed Rep; 2013 Sep; 1(5):771-775. PubMed ID: 24649027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.